Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients

Guglielmo Vetere, Emerik Osterlund, Mahmoud M G Yousef, Songwit Payapwattanawong, Giulia Maddalena, Jumanah Alshenaifi, Kristin D Alfaro, Mark Knafl, Van K Morris, Christine M Parseghian, Kanwal P S Raghav, Robert A Wolff, Arvind Dasari, Michael J Overman, Scott Kopetz, John Paul Shen

Open source

DOI: 10.1136/jitc-2026-015414
Published: 2026-09
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-015414,
  title = {Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients},
  author = {Guglielmo Vetere and Emerik Osterlund and Mahmoud M G Yousef and Songwit Payapwattanawong and Giulia Maddalena and Jumanah Alshenaifi and Kristin D Alfaro and Mark Knafl and Van K Morris and Christine M Parseghian and Kanwal P S Raghav and Robert A Wolff and Arvind Dasari and Michael J Overman and Scott Kopetz and John Paul Shen},
  year = {2026},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2026-015414},
  url = {https://doi.org/10.1136/jitc-2026-015414}
}

RIS

TY  - JOUR
TI  - Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients
AU  - Guglielmo Vetere
AU  - Emerik Osterlund
AU  - Mahmoud M G Yousef
AU  - Songwit Payapwattanawong
AU  - Giulia Maddalena
AU  - Jumanah Alshenaifi
AU  - Kristin D Alfaro
AU  - Mark Knafl
AU  - Van K Morris
AU  - Christine M Parseghian
AU  - Kanwal P S Raghav
AU  - Robert A Wolff
AU  - Arvind Dasari
AU  - Michael J Overman
AU  - Scott Kopetz
AU  - John Paul Shen
PY  - 2026
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-015414
UR  - https://doi.org/10.1136/jitc-2026-015414
ER  -

APA

Vetere, G., Osterlund, E., Yousef, M. M. G., Payapwattanawong, S., Maddalena, G., Alshenaifi, J., Alfaro, K. D., Knafl, M., Morris, V. K., Parseghian, C. M., Raghav, K. P. S., Wolff, R. A., Dasari, A., Overman, M. J., Kopetz, S., & Shen, J. P. (2026). Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015414

Source records

crossref · retrieved 2026-09-25T07:07:50.824Z